155 related articles for article (PubMed ID: 15496156)
1. Heterozygous mice for TGF-betaIIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy.
Kim HW; Kim BC; Song CY; Kim JH; Hong HK; Lee HS
Kidney Int; 2004 Nov; 66(5):1859-65. PubMed ID: 15496156
[TBL] [Abstract][Full Text] [Related]
2. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
3. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis.
Kim JH; Kim BK; Moon KC; Hong HK; Lee HS
Kidney Int; 2003 Nov; 64(5):1715-21. PubMed ID: 14531804
[TBL] [Abstract][Full Text] [Related]
4. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
[TBL] [Abstract][Full Text] [Related]
5. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2007 May; 71(9):882-8. PubMed ID: 17299519
[TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis.
Kasuga H; Ito Y; Sakamoto S; Kawachi H; Shimizu F; Yuzawa Y; Matsuo S
Kidney Int; 2001 Nov; 60(5):1745-55. PubMed ID: 11703592
[TBL] [Abstract][Full Text] [Related]
10. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
11. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.
Song CY; Kim BC; Hong HK; Lee HS
Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021
[TBL] [Abstract][Full Text] [Related]
13. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
14. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
[TBL] [Abstract][Full Text] [Related]
15. GdCl
Li J; Wu B; Hu H; Fang X; Liu Z; Wu S
J Pharmacol Sci; 2020 Feb; 142(2):41-49. PubMed ID: 31831259
[TBL] [Abstract][Full Text] [Related]
16. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
Mizuno S; Nakamura T
Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
Krag S; Nyengaard JR; Wogensen L
Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
19. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.
Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928
[TBL] [Abstract][Full Text] [Related]
20. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.
Han DC; Isono M; Chen S; Casaretto A; Hong SW; Wolf G; Ziyadeh FN
Kidney Int; 2001 Apr; 59(4):1315-23. PubMed ID: 11260392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
